+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Anti-Fungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication, By Infection Type, By Route of Administration, By End User, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026

  • ID: 5450283
  • Report
  • October 2021
  • Region: Global
  • 114 Pages
  • TechSci Research
UP TO OFF
until Dec 31st 2021
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Anti-Fungal Drugs Market is Expected to Reach USD 28484.69 Million by 2026, Growing at CAGR of 10.39% Over the Forecast Period.

FEATURED COMPANIES

  • Abbott Laboratories Inc
  • Bayer AG
  • Galderma SA
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
  • Pfizer Inc.
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Anti-fungal Drugs Market is expected to reach USD28484.69 million by 2026, growing at CAGR of 10.39% over the forecast period. Fungal infections can lead to diseases including fungal pneumonia, candidiasis, mucormycosis, among others and these fungal infections require the dosage of anti-fungal drugs to ensure effective treatment. The increasing prevalence of fungal infections is considered the primary driver for the market growth in the forecast period. The rise in awareness levels among patients regarding the adverse effect of fungal infection on the human body is significantly accelerating the demand for anti-fungal drugs around the world. An increase in government funds and investments to promote research and development activities to formulate anti-fungal drugs is fueling the market growth. An increase in the use of anti-fungal drugs coupled with the rising number of anti-fungal drugs available over-the-counter is expected to boost the market demand. With the surge in popularity of over-the-counter drugs such as ketoconazole, miconazole, econazole, amorolfine, several patients are preferring over-the-counter drugs. The rise in onychomycosis cases, which is a fungal infection affecting fingers and toenails is also considered a major driver responsible for the high demand for anti-fungal drugs.

The Global Anti-fungal Drugs Market is segmented into drug class, indication, infection type, route of administration, end-user, distribution channel, regional distribution, and company. Based on drug class, the market is further divided into azoles, echinocandins, polyenes, allylamines and others. The azoles segment is expected to dominate the anti-fungal drugs market in the forecast period owing to their use in treatment of almost all the indications. Based on indication, the market is segmented into candidiasis, aspergillosis, dermatophytosis, mucormycosis, and others. The candidiasis segment is expected to dominate the market owing to high cases globally associated with the fungal species.

Based on regional analysis, North America is expected to dominate the anti-fungal drugs market for the next five years owing to the presence of major market players in the region. The high prevalence of fungal infections in the region is another crucial factor aiding the market growth. Well-developed healthcare infrastructure and favorable government healthcare policies are the other significant factors bolstering the market growth.

The major players operating in the Global Anti-fungal Drugs Market are Astellas Pharma Inc., GlaxoSmithKline Plc, Bayer AG, Dr. Reddy's Laboratories Ltd., Gilead Sciences Inc., Janssen Pharmaceuticals Inc. (Johnson & Johnson), Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc. (Mylan Laboratories Inc.), Cipla Ltd., Zydus Cadila Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd, Abbott Laboratories Inc., Novartis AG, Galderma SA among others. Major companies are developing advanced technologies and launching new anti-fungal drugs to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of the Global Anti-fungal Drugs Market from 2016 to 2020.
  • To estimate and forecast the market size of the Global Anti-fungal Drugs Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the Global Anti-fungal Drugs Market based on drug class, indication, infection type, route of administration, end-user, distribution channel, regional distribution, and company.
  • To identify dominant region or segment in the Global Anti-fungal Drugs Market.
  • To identify drivers and challenges for the Global Anti-fungal Drugs Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Anti-fungal Drugs Market.
  • To identify and analyze the profile of leading players operating in the Global Anti-fungal Drugs Market.
  • To identify key sustainable strategies adopted by market players in the Global Anti-fungal Drugs Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers who could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers, distribution channels and presence of all major players across the globe.

The publisher calculated the market size of the Global Anti-fungal Drugs Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of various segments for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

  • Anti-fungal drug manufacturing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to anti-fungal drugs market

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:

In this report, the Global Anti-fungal Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Anti-Fungal Drugs Market, By Drug Class:

  • Azoles
  • Echinocandins
  • Polyenes
  • Allylamines
  • Others

Global Anti-Fungal Drugs Market, By Indication:

  • Candidiasis
  • Aspergillosis
  • Mucormycosis
  • Dermatophytosis
  • Others

Global Anti-Fungal Drugs Market, By Infection Type:

  • Superficial Fungal Infection
  • Systemic Fungal Infection

Global Anti-Fungal Drugs Market, By Route of Administration:

  • Topical
  • Oral
  • Parenteral
  • Others

Global Anti-Fungal Drugs Market, By End-User:

  • Homecare
  • Hospitals
  • Clinics
  • Others

Global Anti-Fungal Drugs Market, By Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Global Anti-Fungal Drugs Market, By Region:

  • North America
  • United States
  • Mexico
  • Canada
  • Europe
  • Russia
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Poland
  • Asia-Pacific
  • India
  • China
  • Indonesia
  • Japan
  • South Korea
  • Malaysia
  • Australia
  • South America
  • Brazil
  • Colombia
  • Argentina
  • Middle East & Africa
  • Nigeria
  • Turkey
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anti-fungal Drugs Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories Inc
  • Bayer AG
  • Galderma SA
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
  • Pfizer Inc.
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Anti-Fungal Drugs Market

4. Executive Summary

5. Voice of Customer
5.1. Brand Awareness
5.2. Factors Contributing to the Prevalence of Fungal Diseases
5.3. Commonly Observed Fungal Diseases

6. Global Anti-Fungal Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others)
6.2.2. By Indication (Candidiasis, Aspergillosis, Mucormycosis, Dermatophytosis, Others)
6.2.3. By Infection Type (Superficial Fungal Infection v/s Systemic Fungal Infection)
6.2.4. By Route of Administration (Topical, Oral, Parenteral, Others)
6.2.5. By End User (Homecare, Hospitals, Clinics, Others)
6.2.6. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy)
6.2.7. By Region
6.2.8. By Company (2020)
6.3. Product Market Map

7. North America Anti-Fungal Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Indication
7.2.3. By Infection Type
7.2.4. By Route of Administration
7.2.5. By End User
7.2.6. By Distribution Channel
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Anti-Fungal Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Indication
7.3.1.2.3. By Infection Type
7.3.1.2.4. By Route of Administration
7.3.1.2.5. By End User
7.3.1.2.6. By Distribution Channel
7.3.2. Mexico Anti-Fungal Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Indication
7.3.2.2.3. By Infection Type
7.3.2.2.4. By Route of Administration
7.3.2.2.5. By End User
7.3.2.2.6. By Distribution Channel
7.3.3. Canada Anti-Fungal Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Indication
7.3.3.2.3. By Infection Type
7.3.3.2.4. By Route of Administration
7.3.3.2.5. By End User
7.3.3.2.6. By Distribution Channel

8. Europe Anti-Fungal Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Indication
8.2.3. By Infection Type
8.2.4. By Route of Administration
8.2.5. By End User
8.2.6. By Distribution Channel
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. Russia Anti-Fungal Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Indication
8.3.1.2.3. By Infection Type
8.3.1.2.4. By Route of Administration
8.3.1.2.5. By End User
8.3.1.2.6. By Distribution Channel
8.3.2. Germany Anti-Fungal Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Indication
8.3.2.2.3. By Infection Type
8.3.2.2.4. By Route of Administration
8.3.2.2.5. By End User
8.3.2.2.6. By Distribution Channel
8.3.3. France Anti-Fungal Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Indication
8.3.3.2.3. By Infection Type
8.3.3.2.4. By Route of Administration
8.3.3.2.5. By End User
8.3.3.2.6. By Distribution Channel
8.3.4. United Kingdom Anti-Fungal Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Indication
8.3.4.2.3. By Infection Type
8.3.4.2.4. By Route of Administration
8.3.4.2.5. By End User
8.3.4.2.6. By Distribution Channel
8.3.5. Italy Anti-Fungal Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Indication
8.3.5.2.3. By Infection Type
8.3.5.2.4. By Route of Administration
8.3.5.2.5. By End User
8.3.5.2.6. By Distribution Channel
8.3.6. Spain Anti-Fungal Drugs Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Drug Class
8.3.6.2.2. By Indication
8.3.6.2.3. By Infection Type
8.3.6.2.4. By Route of Administration
8.3.6.2.5. By End User
8.3.6.2.6. By Distribution Channel
8.3.7. Poland Anti-Fungal Drugs Market Outlook
8.3.7.1. Market Size & Forecast
8.3.7.1.1. By Value
8.3.7.2. Market Share & Forecast
8.3.7.2.1. By Drug Class
8.3.7.2.2. By Indication
8.3.7.2.3. By Infection Type
8.3.7.2.4. By Route of Administration
8.3.7.2.5. By End User
8.3.7.2.6. By Distribution Channel

9. Asia-Pacific Anti-Fungal Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Indication
9.2.3. By Infection Type
9.2.4. By Route of Administration
9.2.5. By End User
9.2.6. By Distribution Channel
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. India Anti-Fungal Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Indication
9.3.1.2.3. By Infection Type
9.3.1.2.4. By Route of Administration
9.3.1.2.5. By End User
9.3.1.2.6. By Distribution Channel
9.3.2. China Anti-Fungal Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Indication
9.3.2.2.3. By Infection Type
9.3.2.2.4. By Route of Administration
9.3.2.2.5. By End User
9.3.2.2.6. By Distribution Channel
9.3.3. Indonesia Anti-Fungal Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Indication
9.3.3.2.3. By Infection Type
9.3.3.2.4. By Route of Administration
9.3.3.2.5. By End User
9.3.3.2.6. By Distribution Channel
9.3.4. Japan Anti-Fungal Drugs Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Drug Class
9.3.4.2.2. By Indication
9.3.4.2.3. By Infection Type
9.3.4.2.4. By Route of Administration
9.3.4.2.5. By End User
9.3.4.2.6. By Distribution Channel
9.3.5. South Korea Anti-Fungal Drugs Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Drug Class
9.3.5.2.2. By Indication
9.3.5.2.3. By Infection Type
9.3.5.2.4. By Route of Administration
9.3.5.2.5. By End User
9.3.5.2.6. By Distribution Channel
9.3.6. Malaysia Anti-Fungal Drugs Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Drug Class
9.3.6.2.2. By Indication
9.3.6.2.3. By Infection Type
9.3.6.2.4. By Route of Administration
9.3.6.2.5. By End User
9.3.6.2.6. By Distribution Channel
9.3.7. Australia Anti-Fungal Drugs Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Drug Class
9.3.7.2.2. By Indication
9.3.7.2.3. By Infection Type
9.3.7.2.4. By Route of Administration
9.3.7.2.5. By End User
9.3.7.2.6. By Distribution Channel

10. South America Anti-Fungal Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Indication
10.2.3. By Infection Type
10.2.4. By Route of Administration
10.2.5. By End User
10.2.6. By Distribution Channel
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Anti-Fungal Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Indication
10.3.1.2.3. By Infection Type
10.3.1.2.4. By Route of Administration
10.3.1.2.5. By End User
10.3.1.2.6. By Distribution Channel
10.3.2. Colombia Anti-Fungal Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Class
10.3.2.2.2. By Indication
10.3.2.2.3. By Infection Type
10.3.2.2.4. By Route of Administration
10.3.2.2.5. By End User
10.3.2.2.6. By Distribution Channel
10.3.3. Argentina Anti-Fungal Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Class
10.3.3.2.2. By Indication
10.3.3.2.3. By Infection Type
10.3.3.2.4. By Route of Administration
10.3.3.2.5. By End User
10.3.3.2.6. By Distribution Channel

11. Middle East and Africa Anti-Fungal Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Drug Class
11.2.2. By Indication
11.2.3. By Infection Type
11.2.4. By Route of Administration
11.2.5. By End User
11.2.6. By Distribution Channel
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. Nigeria Anti-Fungal Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Drug Class
11.3.1.2.2. By Indication
11.3.1.2.3. By Infection Type
11.3.1.2.4. By Route of Administration
11.3.1.2.5. By End User
11.3.1.2.6. By Distribution Channel
11.3.2. Turkey Anti-Fungal Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Drug Class
11.3.2.2.2. By Indication
11.3.2.2.3. By Infection Type
11.3.2.2.4. By Route of Administration
11.3.2.2.5. By End User
11.3.2.2.6. By Distribution Channel
11.3.3. South Africa Anti-Fungal Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Drug Class
11.3.3.2.2. By Indication
11.3.3.2.3. By Infection Type
11.3.3.2.4. By Route of Administration
11.3.3.2.5. By End User
11.3.3.2.6. By Distribution Channel
11.3.4. Saudi Arabia Anti-Fungal Drugs Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Drug Class
11.3.4.2.2. By Indication
11.3.4.2.3. By Infection Type
11.3.4.2.4. By Route of Administration
11.3.4.2.5. By End User
11.3.4.2.6. By Distribution Channel
11.3.5. UAE Anti-Fungal Drugs Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Drug Class
11.3.5.2.2. By Indication
11.3.5.2.3. By Infection Type
11.3.5.2.4. By Route of Administration
11.3.5.2.5. By End User
11.3.5.2.6. By Distribution Channel

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled
14.2.1. Astellas Pharma Inc.
14.2.2. GlaxoSmithKline Plc
14.2.3. Bayer AG
14.2.4. Dr. Reddy's Laboratories Ltd.
14.2.5. Gilead Sciences Inc.
14.2.6. Janssen Pharmaceuticals Inc. (Johnson & Johnson)
14.2.7. Pfizer Inc.
14.2.8. Sanofi S.A.
14.2.9. Merck & Co., Inc.
14.2.10. Glenmark Pharmaceuticals Ltd.
14.2.11. Sun Pharmaceuticals Industries Ltd.
14.2.12. Teva Pharmaceutical Industries Ltd.
14.2.13. Viatris Inc. (Mylan Laboratories Inc.)
14.2.14. Cipla Ltd.
14.2.15. Zydus Cadila Ltd.
14.2.16. Lupin Ltd.
14.2.17. Torrent Pharmaceuticals Ltd
14.2.18. Abbott Laboratories Inc
14.2.19. Novartis AG
14.2.20. Galderma SA

15. Strategic Recommendations

16. About the Publisher & Disclaimer

List of Figures


Figure 1: Global Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 2: Global Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 3: Global Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 4: Global Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 5: Global Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 6: Global Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 7: Global Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 8: Global Anti-Fungal Drugs Market Share, By Region, By Value, 2016-2026
Figure 9: Global Anti-Fungal Drugs Market Share, By Company, By Value, 2020
Figure 10: Global Anti-Fungal Drugs Product Market Map, By Value, 2016-2026F
Figure 11: North America Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 12: North America Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 13: North America Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 14: North America Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 15: North America Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 16: North America Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 17: North America Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 18: North America Anti-Fungal Drugs Market Share, By Country, By Value, 2016-2026F
Figure 19: United States Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 20: United States Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 21: United States Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 22: United States Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 23: United States Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 24: United States Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 25: United States Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 26: Mexico Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 27: Mexico Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 28: Mexico Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 29: Mexico Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 30: Mexico Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 31: Mexico Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 32: Mexico Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 33: Canada Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 34: Canada Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 35: Canada Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 36: Canada Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 37: Canada Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 38: Canada Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 39: Canada Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 40: Europe Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 41: Europe Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 42: Europe Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 43: Europe Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 44: Europe Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 45: Europe Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 46: Europe Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 47: Europe Anti-Fungal Drugs Market Share, By Country, By Value, 2016-2026F
Figure 48: Russia Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 49: Russia Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 50: Russia Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 51: Russia Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 52: Russia Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 53: Russia Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 54: Russia Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 55: Germany Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 56: Germany Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 57: Germany Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 58: Germany Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 59: Germany Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 60: Germany Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 61: Germany Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 62: France Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 63: France Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 64: France Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 65: France Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 66: France Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 67: France Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 68: France Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 69: United Kingdom Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 70: United Kingdom Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 71: United Kingdom Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 72: United Kingdom Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 73: United Kingdom Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 74: United Kingdom Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 75: United Kingdom Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 76: Italy Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 77: Italy Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 78: Italy Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 79: Italy Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 80: Italy Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 81: Italy Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 82: Italy Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 83: Spain Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 84: Spain Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 85: Spain Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 86: Spain Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 87: Spain Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 88: Spain Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 89: Spain Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 90: Poland Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 91: Poland Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 92: Poland Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 93: Poland Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 94: Poland Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 95: Poland Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 96: Poland Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 97: Asia-Pacific Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 98: Asia-Pacific Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 99: Asia-Pacific Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 100: Asia-Pacific Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 101: Asia-Pacific Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 102: Asia-Pacific Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 103: Asia-Pacific Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 104: Asia-Pacific Anti-Fungal Drugs Market Share, By Country, By Value, 2016-2026F
Figure 105: India Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 106: India Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 107: India Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 108: India Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 109: India Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 110: India Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 111: India Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 112: China Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 113: China Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 114: China Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 115: China Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 116: China Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 117: China Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 118: China Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 119: Indonesia Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 120: Indonesia Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 121: Indonesia Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 122: Indonesia Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 123: Indonesia Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 124: Indonesia Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 125: Indonesia Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 126: Japan Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 127: Japan Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 128: Japan Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 129: Japan Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 130: Japan Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 131: Japan Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 132: Japan Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 133: South Korea Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 134: South Korea Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 135: South Korea Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 136: South Korea Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 137: South Korea Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 138: South Korea Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 139: South Korea Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 140: Malaysia Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 141: Malaysia Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 142: Malaysia Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 143: Malaysia Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 144: Malaysia Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 145: Malaysia Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 146: Malaysia Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 147: Australia Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 148: Australia Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 149: Australia Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 150: Australia Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 151: Australia Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 152: Australia Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 153: Australia Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 154: South America Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 155: South America Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 156: South America Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 157: South America Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 158: South America Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 159: South America Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 160: South America Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 161: South America Anti-Fungal Drugs Market Share, By Country, By Value, 2016-2026F
Figure 162: Brazil Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 163: Brazil Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 164: Brazil Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 165: Brazil Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 166: Brazil Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 167: Brazil Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 168: Brazil Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 169: Colombia Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 170: Colombia Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 171: Colombia Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 172: Colombia Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 173: Colombia Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 174: Colombia Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 175: Colombia Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 176: Argentina Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 177: Argentina Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 178: Argentina Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 179: Argentina Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 180: Argentina Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 181: Argentina Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 182: Argentina Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 183: Middle East and Africa Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 184: Middle East and Africa Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 185: Middle East and Africa Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 186: Middle East and Africa Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 187: Middle East and Africa Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 188: Middle East and Africa Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 189: Middle East and Africa Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 190: Middle East and Africa Anti-Fungal Drugs Market Share, By Country, By Value, 2016-2026F
Figure 191: Nigeria Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 192: Nigeria Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 193: Nigeria Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 194: Nigeria Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 195: Nigeria Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 196: Nigeria Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 197: Nigeria Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 198: Turkey Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 199: Turkey Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 200: Turkey Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 201: Turkey Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 202: Turkey Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 203: Turkey Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 204: Turkey Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 205: South Africa Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 206: South Africa Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 207: South Africa Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 208: South Africa Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 209: South Africa Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 210: South Africa Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 211: South Africa Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 212: Saudi Arabia Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 213: Saudi Arabia Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 214: Saudi Arabia Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 215: Saudi Arabia Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 216: Saudi Arabia Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 217: Saudi Arabia Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 218: Saudi Arabia Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Figure 219: UAE Anti-Fungal Drugs Market Size, By Value (USD Million), 2016-2026F
Figure 220: UAE Anti-Fungal Drugs Market Share, By Drug Class, By Value, 2016-2026F
Figure 221: UAE Anti-Fungal Drugs Market Share, By Indication, By Value, 2016-2026F
Figure 222: UAE Anti-Fungal Drugs Market Share, By Infection Type, By Value, 2016-2026F
Figure 223: UAE Anti-Fungal Drugs Market Share, By Route of Administration, By Value, 2016-2026F
Figure 224: UAE Anti-Fungal Drugs Market Share, By End User, By Value, 2016-2026F
Figure 225: UAE Anti-Fungal Drugs Market Share, By Distribution Channel, By Value, 2016-2026F
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Astellas Pharma Inc.
  • GlaxoSmithKline Plc
  • Bayer AG
  • Dr. Reddy's Laboratories Ltd.
  • Gilead Sciences Inc.
  • Janssen Pharmaceuticals Inc. (Johnson & Johnson)
  • Pfizer Inc.
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Sun Pharmaceuticals Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc. (Mylan Laboratories Inc.)
  • Cipla Ltd.
  • Zydus Cadila Ltd.
  • Lupin Ltd.
  • Torrent Pharmaceuticals Ltd
  • Abbott Laboratories Inc
  • Novartis AG
  • Galderma SA
Note: Product cover images may vary from those shown
Adroll
adroll